NuCana plc Sponsored ADR
(NASDAQ: NCNA)

NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

4.170

-0.260 (-5.87%)
Range 4.170 - 4.540   (8.87%)
Open 4.450
Previous Close 4.430
Bid Price 0.850
Bid Volume 8
Ask Price 0.900
Ask Volume 12
Volume 53,133
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 05:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis